COVID-19: FDA reporting patterns
174,599 FDA FAERS reports mention COVID-19. 98,559 reports have a serious outcome flag.
Medicines named as suspect
- Ritonavir: 22,358 reports
- Nirmatrelvir: 22,134 reports
- Ocrelizumab: 11,518 reports
- Adalimumab: 9,890 reports
- Dupilumab: 7,403 reports
- Rituximab: 7,030 reports
- Lenalidomide: 6,369 reports
- Infliximab: 6,176 reports
- Tofacitinib: 4,968 reports
- Secukinumab: 3,913 reports
- Human Immunoglobulin G: 3,395 reports
- Prednisone: 3,339 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.